Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

WHAT'S NEW

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Sep 7 2021

Full Issue

Message Of Vaccine Efficacy Getting Lost, Health Experts Worry

Emphasizing that the original goal of the covid vaccine was to protect against severe forms of the disease is key to getting more shots in arms, public health officials say. News outlets also report on new ways that the vaccine could reach more people.

Axios: The COVID Vaccines Are Still The Pandemic's Endgame 

The goal of the COVID-19 vaccines was always to reduce death and severe illness. Even with the Delta variant, the vaccines are still doing that. But that message is getting lost, infectious disease and vaccine experts tell Axios. Two-thirds of the world isn't fully vaccinated. To return to some semblance of "normal," health authorities need to emphasize how the vaccines aren't failing and drastically increase global vaccine production. (Herman, 9/7)

AP: Afghan Refugees At Fort McCoy Offered COVID-19 Vaccines

Afghan refugees at Fort McCoy are being offered free COVID-19 vaccines — one of many precautions being taken at the military base to prevent the spread of the virus. The U.S. Department of Homeland Security said all Afghans and U.S. residents coming from Afghanistan are tested for COVID when they first arrive to the U.S. and have the option to get a COVID-19 vaccine either at the airport or at Department of Defense facilities. (9/6)

Atlanta Journal-Constitution: Gwinnett School District To Offer $500 Vaccine Incentive

Gwinnett County Public Schools is offering a one-time $500 incentive to eligible staff members who get fully vaccinated against COVID-19. Employees who were vaccinated earlier this year are also eligible for the payments, according to a news release from the school district. The incentive is available to all full-time employees with benefits as well as contracted cafeteria staff and speech language pathologists. (Malik, 9/7)

The New York Times: The Best Birthday Present In 2021? A Covid Vaccine. 

Zoe Tu, a seventh grader in Brooklyn, likes to celebrate her birthday with dulce de leche Haagen-Dazs ice cream cake. This year, her 12th, was no exception, but the day was also marked by a treat of another kind: her Covid vaccine. Zoe got the shot the first day she became eligible, on Aug. 2, and it was accompanied by a $100 gift certificate given as a vaccine incentive at the Barclays Center. (Her mother allowed her to spend it on anything she wanted.) “The nurse was really excited about wishing me a happy birthday,” Zoe recalled. (Goldberg, 9/5)

In other updates on the vaccine rollout —

CIDRAP: Study Shows Minimal Risk Of Guillain-Barre Relapse After COVID Vaccine

Only 1 of 702 adults who previously had Guillain-Barre syndrome (GBS) needed medical care for a relapse after receiving the Pfizer/BioNTech COVID-19 vaccine, finds a study yesterday in JAMA Neurology. Researchers at Maccabi Healthcare Services in Tel Aviv and Haifa, Israel, conducted the retrospective study to evaluate the country's policy of not excluding people previously diagnosed as having GBS from receiving the vaccine. An earlier association between other vaccines and GBS had raised concerns among clinicians and patients about COVID-19 vaccines. (9/2)

Stat: CEPI Warns Of Major Hurdle To Developing New Covid-19 Vaccines 

The world still needs more — and better — Covid-19 vaccines. But a major hurdle stands in the way of the development of new vaccines, as well as the critical studies needed to determine the best way to use these important tools, the Coalition for Epidemic Preparedness Innovations (CEPI) warned in a letter published Tuesday in the journal Nature. Unless countries that have purchased vaccine doses and companies that have already brought vaccines into use agree to find ways to resolve the problem, manufacturers that trail the first wave of producers may not be able to prove that their vaccines work. (Branswell, 9/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF